Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products

الملخص

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.